Search

everythinglearnresearchcommunity

for

Search:↓

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Corticosteroids and topical irritants are used to treat alopecia areata.

Cyclosporin A and FK506 can start new hair growth without needing immunosuppression.

Methotrexate, resveratrol, and curcumin may help treat alopecia areata by targeting immune cells.

Intestinal intraepithelial lymphocytes are crucial for gut immunity and maintaining the mucosal barrier.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

DNCB is highly effective for treating alopecia areata with minimal long-term side effects.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with less inflammation.

Biodegradable scaffolds help regenerate wounds and hair by activating the immune system.

A new treatment effectively kills antibiotic-resistant bacteria and helps wounds heal faster by boosting the immune response.

TYK2 inhibitors show promise for treating cancer and autoimmune disorders.

New treatments for the autoimmune hair loss condition alopecia areata may include JAK inhibitors and other immunomodulators.

The role of γδT-cells in causing alopecia areata remains unclear.

Apremilast may help treat hair loss in alopecia areata.

New cancer drugs often cause skin and nail problems.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

Mast cell and nerve fiber interactions in mouse skin change with the hair cycle.

Hair dye may trigger anti-GBM disease relapse, and rituximab can help manage it.

Treg cells help repair and regenerate tissues by interacting with local cells.

Mycophenolate mofetil can effectively treat autoimmune hepatitis when standard drugs fail.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

The microreactor effectively fights antibiotic-resistant infections and promotes tissue healing.

Atopic dermatitis in kids with alopecia areata can predict poor response to topical immunotherapy.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

Combining low-dose oral minoxidil with immunomodulators shows promise for treating alopecia areata but needs more research.

New treatments for alopecia areata may target specific immune cells and pathways involved in hair loss.

Anti-Desmocollin 3 antibodies can cause atypical pemphigus symptoms.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Cytokines are important for immune responses and treating diseases, but they can cause side effects like fever and skin issues.

JAK inhibitors are effective treatments for alopecia areata.